A. Holzmann et al., Inhibition of lung phosphodiesterase improves responsiveness to inhaled nitric oxide in isolated-perfused lungs from rats challenged with endotoxin, INTEN CAR M, 27(1), 2001, pp. 251-257
Objectives:To investigate the ability of phosphodiesterase (PDE) selective
inhibitors to improve responsiveness to inhaled nitric oxide (NO) in isolat
ed-perfused lungs of rats pretreated with endotoxin/lipopolysaccharide (LPS
).
Design and setting: Prospective, controlled animal study in the animal rese
arch facility of a university hospital.
Interventions: Sixteen hours after adult Sprague-Dawley rats were injected
intraperitoneally with 0.4 mg/ kg E. coli 0111:B4 LPS administration, lungs
were isolated and perfused, and the thromboxane mimetic U46619 was employe
d to increase the mean pulmonary artery pressure by 5-7 mmHg. The lungs wer
e then ventilated with or without 0.4 ppm NO, and erythro-9-(2-hydroxy-3-no
nyl) adenine (EHNA; PDE type 2 inhibitor), milrinone (PDE type 3 inhibitor)
, or zaprinast (inhibitor of PDE types 5 and 9) were added to the perfusate
.
Measurements and results: In the presence of EHNA (12.5, 25, 50 muM) the va
sodilator response to inhaled NO was not greater than in its absence (0.25
+/- 0.25, 0.5 +/- 0.25, 0.75 +/- 0.25 mmHg vs. 0.25 +/- 0.25, 0.5 +/- 0.25,
0.75 +/- 0.25 mmHg, re spectively). In the presence of milrinone (125, 250
, 500 nM), the vasodilator response to inhaled NO was also not improved. In
contrast, zaprinast (3.7, 7.4, 14.8 muM) augmented the pulmonary vasodilat
ory effect of inhaled NO in lungs from LPS-pretreated rats from 0.25 +/- 0.
25, 0.5 +/- 0.25, 0.75 +/- 0.25 mmHg to 0.75 +/- 0.25, 1.5 +/- 0.5, 1.75 +/
- 0.75 mmHg, respectively (p < 0.05).
Conclusions: Our results demonstrate that inhibition of pulmonary PDE enzym
e activity with zaprinast increases vasodilator responsiveness to inhaled N
O in lungs obtained from rats 16 h after LPS challenge.